Eligibility
18+
All Sexes
What conditions do you have?
Select
Study Summary
This trial will compare the outcomes of exposure and response prevention (ERP), the sole evidence-based psychotherapy for OCD, to those of a control condition among Veterans with OCD.
Eligible Conditions
- Disease
- Comorbid Post-Traumatic Stress Disorder and OCD
- Obsessive-Compulsive Disorder
Treatment Effectiveness
Effectiveness Progress
Other trials for Disease
Study Objectives
1 Primary · 2 Secondary · Reporting Duration: Baseline, Post Treatment (4-6 Months after Randomization), 6 Months Post Treatment
Month 6
Adult OCD Impact Scale (AOIS) - Change
Columbia Suicide Severity Rating Scale (C-SSRS) - Suicidality - Change
Generalized Anxiety Disorder-7 scale (GAD-7) - Anxiety Symptoms - Change
Obsessive-Compulsive Inventory, Revised (OCI-R) - Change
PTSD Checklist (PCL-5) - PTSD Symptoms - Change
Mental Depression
Quality of Life Enjoyment and Satisfaction Questionnaire, short form (QLESQ-SF) - Change
Work and Social Adjustment Scale (WSAS) - Change
Yale-Brown Obsessive Compulsive Scale, self-report form (Y-BOCS) - Change
Month 6
Quality of Life and Functional Status (SF-12V) - Change
Trial Safety
Safety Progress
Other trials for Disease
Trial Design
1 Treatment Group
Exposure and Response Prevention (ERP)
1 of 1
Experimental Treatment
160 Total Participants · 1 Treatment Group
Primary Treatment: Exposure and Response Prevention · No Placebo Group · N/A
Exposure and Response Prevention (ERP)
Behavioral
Experimental Group · 1 Intervention: Exposure and Response Prevention · Intervention Types: BehavioralTreatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Exposure and Response Prevention
2013
Completed Phase 4
~260
Trial Logistics
Trial Timeline
Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: baseline, post treatment (4-6 months after randomization), 6 months post treatment
Who is running the clinical trial?
VA Office of Research and DevelopmentLead Sponsor
1,472 Previous Clinical Trials
2,741,534 Total Patients Enrolled
83 Trials studying Disease
12,391 Patients Enrolled for Disease
Terri L. Fletcher, PhDPrincipal InvestigatorMichael E. DeBakey VA Medical Center, Houston, TX
1 Previous Clinical Trials
225 Total Patients Enrolled
Eligibility Criteria
Age 18+ · All Participants · 2 Total Inclusion Criteria
Mark “yes” if the following statements are true for you:You are willing to participate in ERP.
About The Reviewer
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.
Popular Clinical Trials
Top Clinical Trials in Cities
Relevant Clinical Trials
Unbiased Results
We believe in providing patients with all the options.Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.Back to top
Conditions
Cancer Related
Treatments